Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses

Qi, Furong, Qian, Shen, Zhang, Shuye, Zhang, Zheng·2020·Biochemical and Biophysical Research Communications
DOI 10.1016/j.bbrc.2020.03.044

Cited by (912)

Items 101–200 of 912

  1. Sexual dimorphism in COVID-19: potential clinical and public health implications
    Nicole Bechmann, Andreas Barthel, Andreas Schedl, Stephan Herzig, Zsuzsanna Varga, Cathérine Gebhard, Manuel Mayr, Constanze Hantel, Felix Beuschlein, Christian Wolfrum et al. · 2022 · Publikationen an der Universität Bielefeld (Universität Bielefeld)
  2. Sexual dimorphism in COVID-19: potential clinical and public health implications
    Nicole Bechmann, Andreas Barthel, Andreas Schedl, Stephan Herzig, Zsuzsanna Varga, Cathérine Gebhard, Manuel Mayr, Constanze Hantel, Felix Beuschlein, Christian Wolfrum et al. · 2022 · The Lancet Diabetes & Endocrinology
  3. The aging transcriptome and cellular landscape of the human lung in relation to SARS-CoV-2
    Ryan Dz-Wei Chow, Medha Majety, Sidi Chen · 2021 · Nature Communications
  4. Immunomodulatory activity of β-glucan polysaccharides isolated from different species of mushroom – A potential treatment for inflammatory lung conditions
    Emma J. Murphy, Emanuele Rezoagli, Robert Edward Pogue, Bianca Simonassi-Paiva, Ismin Zainol Abidin, Gustavo Waltzer Fehrenbach, Emer O'Neil, Ian Major, John Gerard Laffey, Neil J. Rowan · 2021 · The Science of The Total Environment
  5. Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation
    Elena Campione, Terenzio Cosio, Luigi Rosa, Caterina Lanna, Stefano Di Girolamo, Roberta Gaziano, Piera Valenti, Luca Bianchi · 2020 · International Journal of Molecular Sciences
  6. Animal models for COVID-19: advances, gaps and perspectives
    Changfa Fan, Yong Wu, Rui Xiong, Yuansong Yang, Chen Ling, Susu Liu, Shunan Liu, Youchun Wang · 2022 · Signal Transduction and Targeted Therapy
  7. ACE2 receptor expression in testes: implications in coronavirus disease 2019 pathogenesis†
    Saguna Verma, Sarini Saksena, Hooman Sadri‐Ardekani · 2020 · Biology of Reproduction
  8. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses
    Anna Artese, Valentina Svicher, Giosuè Costa, Romina Salpini, Velia Chiara Di Maio, Mohammad Alkhatib, Francesca Alessandra Ambrosio, Maria Mercedes Santoro, Yehuda G. Assaraf, Stefano Alcaro et al. · 2020 · Drug Resistance Updates
  9. SARS‐CoV‐2 infection and multi-organ system damage: A review
    Ali Ahmed Rabaan, Samira Smajlović, Hüseyin Tombuloğlu, Sabahudin Ćordić, Azra Hajdarević, Nudžejma Kudić, Abbas Al Mutai, Safaa Abdulrahman Turkistani, Shamsah H. Al-Ahmed, Nisreen A. Al-Zaki et al. · 2022 · Biomolecules and Biomedicine
  10. Hepatic consequences of COVID-19 infection. Lapping or biting?
    Piero Portincasa, Marcin Jan Krawczyk, Antonia Machill, Frank Lammert, Agostino Di Ciaula · 2020 · European Journal of Internal Medicine
  11. DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
    Inés Valencia, Concepción Peiró, Óscar Lorenzo, Carlos F. Sánchez‐Ferrer, Jürgen Eckel, Tania Romacho · 2020 · Frontiers in Pharmacology
  12. Organoids: a novel modality in disease modeling
    Zahra Heydari, Farideh Moeinvaziri, Tarun Agarwal, Paria Pooyan, Anastasia I. Shpichka, Tapas K. Maiti, Peter S. Timashev, Hossein Baharvand, Massoud Vosough · 2021 · Bio-Design and Manufacturing
  13. Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges
    Hongpeng Jia, Enid Neptune, Honggang Cui · 2020 · American Journal of Respiratory Cell and Molecular Biology
  14. SARS-CoV-2 Induces Lymphocytopenia by Promoting Inflammation and Decimates Secondary Lymphoid Organs
    Qun Xiang, Zeqing Feng, Bo Diao, Chao Tu, Qinghua Qiao, Han Yang, Yi Zhang, Gang Wang, Huiming Wang, Chenhui Wang et al. · 2021 · Frontiers in Immunology
  15. Expression of ACE2 in airways: Implication for COVID‐19 risk and disease management in patients with chronic inflammatory respiratory diseases
    Yin Yao, Hai Wang, Zheng Liu · 2020 · Clinical & Experimental Allergy
  16. Implications of gastrointestinal manifestations of COVID-19
    Lijing Yang, Lei Tu · 2020 · The Lancet. Gastroenterology & hepatology
  17. Could the Induction of Trained Immunity by β-Glucan Serve as a Defense Against COVID-19?
    Anne E. Geller, Jun Yan · 2020 · Frontiers in Immunology
  18. Follow-Ups on Persistent Symptoms and Pulmonary Function Among Post-Acute COVID-19 Patients: A Systematic Review and Meta-Analysis
    Qiuyue Long, Jiwei Li, Xiaoyi Hu, Yangyuyan Bai, Yali Zheng, Zhancheng Gao · 2021 · Frontiers in Medicine
  19. Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases
    George El-Arif, Shaymaa Khazaal, Antonella Farhat, Julien Harb, Cédric Annweiler, Yingliang Wu, Zhijian Cao, Hervé Kovacic, Ziad Abi Khattar, Ziad Fajloun et al. · 2022 · Molecules
  20. The Surviving Sepsis Campaign: Research Priorities for Coronavirus Disease 2019 in Critical Illness
    Craig M. Coopersmith, Massimo M. Antonelli, Seth R. Bauer, Clifford Scott Deutschman, Laura Evans, Ricard Ferrer, Judith Hellman, Sameer Jog, Jozef Kesecioğlu, Niranjan “Tex” Kissoon et al. · 2021 · Critical Care Medicine
  21. Ocular Surface Expression of SARS-CoV-2 Receptors
    Andrea Leonardi, Umberto Rosani, Paola Brun · 2020 · Ocular Immunology and Inflammation
  22. Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection
    Nazzarena Labò, Hidetaka Ohnuki, Giovanna Tosato · 2020 · Cells
  23. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart
    Hanning Liu, Shujie Gai, Xiaoyi Wang, Juntong Zeng, Cheng Sun, Yan Zhao, Zhe Zheng · 2020 · Cardiovascular Research
  24. SARS-CoV-2 receptor networks in diabetic and COVID-19–associated kidney disease
    Rajasree Menon, Edgar A. Otto, Rachel S. G. Sealfon, Viji Nair, Aaron K. Wong, Chandra L. Theesfeld, Xi Chen, Yuan Wang, Avinash Boppana, Jinghui Luo et al. · 2020 · Kidney International
  25. Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission
    Daniella Sabino Battagello, Guilherme Dragunas, Marianne Klein, Ana Luísa P. Ayub, Fernando Janczur Velloso, Ricardo G. Correa · 2020 · Clinical Science
  26. MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19
    Christine Hum, Julia Loiselle, Nadine Ahmed, Tyler A. Shaw, Caroline Toudic, John Paul Pezacki · 2021 · Drugs
  27. Acute Kidney Injury in SARS-CoV-2 Infection: Direct Effect of Virus on Kidney Proximal Tubule Cells
    Manoocher Soleimani · 2020 · International Journal of Molecular Sciences
  28. Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs
    Taejoon Won, Megan Kay Wood, David M. Hughes, Monica Vladut Talor, Zexu Ma, Jowaly Schneider, JOHN T. SKINNER, Beejan Asady, Erin Goerlich, Marc K. Halushka et al. · 2022 · EBioMedicine
  29. Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
    Francesca Rossi, Chiara Tortora, Maura Argenziano, Alessandra Di Paola, Francesca Punzo · 2020 · International Journal of Molecular Sciences
  30. In Vitro and In Vivo Models for Studying SARS-CoV-2, the Etiological Agent Responsible for COVID-19 Pandemic
    Rafael Borges Rosa, Willyenne Marília Dantas, Jéssica Catarine Frutuoso do Nascimento, Murilo Vieira da Silva, Ronaldo N. de Oliveira, Lindomar Pena · 2021 · Viruses
  31. Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8+ T cells
    Malte Lehmann, Kristina Allers, Claudia Heldt, Jenny Meinhardt, Franziska Schmidt, Yasmina Rodriguez‐Sillke, Désirée Kunkel, Michael Schümann, Chotima Böttcher, Christiane Stahl‐Hennig et al. · 2021 · Mucosal Immunology
  32. Coronavirus disease 2019 (COVID-19) in neurology and neurosurgery: A scoping review of the early literature
    Mitchell Patrick Wilson, Andrew S Jack · 2020 · Clinical Neurology and Neurosurgery
  33. Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies
    Praveen Mathews Varghese, Anthony George Tsolaki, Hadida Yasmin, Abhishek Shastri, Janez Ferluga, Manu Vatish, Taruna Madan, Uday Kishore · 2020 · Immunobiology
  34. SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study
    Sanjay Pandanaboyana, John A. G. Moir, John Samuel Leeds, Kofi W. Oppong, Aditya Kanwar, Ahmed M. S. M. Marzouk, Ajay P. Belgaumkar, Ajay Kumar Gupta, Ajith Kumar Siriwardena, Ali Raza Haque et al. · 2021 · Gut
  35. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
    Qin Ning, Di Wu, Xiaojing Wang, Dong Xi, Tao Chen, Guang Chen, Hongwu Wang, Huiling Lü, Ming Wang, Lin Zhu et al. · 2022 · Signal Transduction and Targeted Therapy
  36. SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic
    Fotini Boufidou, Snežana Medić, Vicky Lampropoulou, Nikolaos Siafakas, Athanasios Tsakris, Cleo G. Anastassopoulou · 2023 · International Journal of Molecular Sciences
  37. Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus1
    Tasnim H. Beacon, Geneviève P. Delcuve, James Davie · 2020 · Genome
  38. High Throughput Multi-Omics Approaches for Clinical Trial Evaluation and Drug Discovery
    Jessica Zielinski, Jason J. Luke, Silvia Guglietta, Carsten Krieg · 2021 · Frontiers in Immunology
  39. Single-cell RNA sequencing of the Strongylocentrotus purpuratus larva reveals the blueprint of major cell types and nervous system of a non-chordate deuterostome
    Periklis Paganos, Danila Voronov, Jacob M. Musser, Detlev Arendt, Maria Ina Arnone · 2021 · eLife
  40. Targeting SARS-CoV-2 receptors as a means for reducing infectivity and improving antiviral and immune response: an algorithm-based method for overcoming resistance to antiviral agents
    Ram Gelman, Areej Bayatra, Asa Kessler, Asaf Schwartz, Yaron Ilan · 2020 · Emerging Microbes & Infections
  41. A systematic review on COVID-19: urological manifestations, viral RNA detection and special considerations in urological conditions
    Vinson Wai‐Shun Chan, Peter Ka‐Fung Chiu, Chi‐Hang Yee, Yuhong Yuan, Chi‐Fai Ng, Jeremy Yuen‐Chun Teoh · 2020 · World Journal of Urology
  42. Implications of SARS‐CoV‐2 infection for neurogastroenterology
    Giovanni Marasco, Marco Vincenzo Lenti, Cesare Cremon, Maria Raffaella Barbaro, Vincenzo Stanghellini, Antonio Di Sabatino, Giovanni Barbara · 2021 · Neurogastroenterology & Motility
  43. Immunomodulatory and Antiviral Activity of Metformin and Its Potential Implications in Treating Coronavirus Disease 2019 and Lung Injury
    Xianyang Chen, Huifang Guo, Qiu Li, Chengdong Zhang, Qiang Deng, Qibin Leng · 2020 · Frontiers in Immunology
  44. Sterilizing Immunity against SARS‐CoV‐2 Infection in Mice by a Single‐Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist‐Adjuvanted Recombinant Spike Protein Vaccine**
    Sonia Jangra, Jana De Vrieze, Angela Choi, Raveen Rathnasinghe, Gabriel Laghlali, Annemiek Uvyn, Simon Van Herck, Lutz Nuhn, Kim Deswarte, Zifu Zhong et al. · 2021 · Angewandte Chemie International Edition
  45. Surface Glycan Modification of Cellular Nanosponges to Promote SARS-CoV-2 Inhibition
    Xiangzhao Ai, Dan Wang, Anna N. Honko, Yaou Duan, Igor Gavrish, Ronnie H. Fang, Anthony Griffiths, Weiwei Gao, Liangfang Zhang · 2021 · Journal of the American Chemical Society
  46. Pathological findings in the postmortem liver of patients with coronavirus disease 2019 (COVID-19)
    Chaohui Lisa Zhao, Amy Rapkiewicz, Mona Maghsoodi-Deerwester, Mala R. Gupta, Wenqing Cao, Thomas A. Palaia, Jianhong Zhou, Bebu Ram, Duc Vo, Behnam Rafiee et al. · 2020 · Human Pathology
  47. Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients
    Shobi Veleri · 2021 · Experimental Brain Research
  48. The use of renin–angiotensin–aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID‐19 patients: A systematic review and meta‐analysis
    Yixuan Wang, Baixin Chen, Yun Li, Lei Zhang, Yuyi Wang, Shuaibing Yang, Xue Xiao, Qingsong Qin · 2020 · Journal of Medical Virology
  49. Associations Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blocker Use, Gastrointestinal Symptoms, and Mortality Among Patients With COVID-19
    Niandi Tan, Yun Qiu, Xiang-Bin Xing, Subrata K. Ghosh, Minhu Chen, Ren Mao · 2020 · Gastroenterology
  50. Involvement of digestive system in COVID-19: manifestations, pathology, management and challenges
    Song Su, Jun Shen, Liangru Zhu, Yun Qiu, Jinshen He, Jinyu Tan, Marietta Iacucci, Siew C. Ng, Subrata K. Ghosh, Ren Mao et al. · 2020 · Therapeutic Advances in Gastroenterology
  51. The Prevalence of Gastrointestinal Symptoms, Abnormal Liver Function, Digestive System Disease and Liver Disease in COVID-19 Infection
    Zi-yuan Dong, Bingjie Xiang, Min Jiang, Ming-jun Sun, Cong Dai · 2020 · Journal of Clinical Gastroenterology
  52. Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus
    Calvin Andeve Omolo, Nikki Soni, Victoria Oluwaseun Fasiku, Irene Mackraj, Thirumala Govender · 2020 · European Journal of Pharmacology
  53. Inhaled ACE2-engineered microfluidic microsphere for intratracheal neutralization of COVID-19 and calming of the cytokine storm
    Zhen Wang, Lei Xiang, Feng Lin, Zhengwei Cai, Huitong Ruan, Juan Wang, Jing Liang, Fei Wang, Min M. Lu, Wenguo Cui · 2021 · Matter
  54. Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies
    Gilberto Vargas‐Alarcón, Rosalinda Posadas‐Sánchez, Julián Ramírez‐Bello · 2020 · Life Sciences
  55. Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions
    Yujie Jiang, Tingmei Zhao, Xueyan Zhou, Xiang Yu, Pedro Gutiérrez‐Castrellón, Xuelei Ma · 2022 · MedComm
  56. Gastrointestinal and hepatic abnormalities in patients with confirmed COVID‐19: A systematic review and meta‐analysis
    Ahmadreza Zarifian, Mohammad Zamiri Bidary, Soheil Arekhi, Mahdi Rafiee, Hanieh Gholamalizadeh, Amirhossein Amiriani, Mohammad Sajjad Ghaderi, Majid Khadem‐Rezaiyan, Mahnaz Amini, Azita Ganji · 2020 · Journal of Medical Virology
  57. Expression of SARS-CoV-2-related receptors in cells of the neurovascular unit: implications for HIV-1 infection
    Silvia Torices, Rosalba Cabrera, Michael Stangis, Oandy Naranjo, Nikolai S. Fattakhov, Tímea Téglás, Daniel Adesse, Michal J. Toborek · 2021 · Journal of Neuroinflammation
  58. Duration of post–COVID-19 symptoms is associated with sustained SARS-CoV-2–specific immune responses
    Jacob K. Files, Sanghita Sarkar, Tim Fram, Sushma Boppana, Sarah Sterrett, Kai Qin, Anju Bansal, Dustin Marsh Long, Steffanie Sabbaj, James J. Kobie et al. · 2021 · JCI Insight
  59. SARS-CoV-2 cell entry beyond the ACE2 receptor
    Shamila D. Alipoor, Mehdi Seyed Mirsaeidi · 2022 · Molecular Biology Reports
  60. Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19)
    Ehsaneh Khodadadi, Parham Maroufi, Ehsan Khodadadi, Isabella Esposito, Khudaverdi Ganbarov, Silvano Espsoito, Mehdi Yousefi, Elham Zeinalzadeh, Hossein Samadi Kafil · 2020 · Microbial Pathogenesis
  61. Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes
    Ceren Güney, Fatma Akar · 2021 · Journal of Pharmacy & Pharmaceutical Sciences
  62. COVID‐19: Focus on the lungs but do not forget the gastrointestinal tract
    Wiktor Smyk, Maciej K. Janik, Piero Portincasa, Piotr Milkiewicz, Frank Lammert, Marcin Jan Krawczyk · 2020 · European Journal of Clinical Investigation
  63. Establishment of an African green monkey model for COVID-19
    Courtney B. Woolsey, Viktoriya Borisevich, Abhishek N. Prasad, Krystle N. Agans, Daniel J. Deer, Natalie S. Dobias, John C. Heymann, Stephanie L. Foster, Corri B. Levine, Liana O. Medina et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  64. Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?
    Fatma Elrashdy, Elrashdy M Moustafa Mohamed Redwan, Vladimir Nikolaevich Uversky · 2020 · Biomolecules
  65. Olfactory and gustatory dysfunction in COVID‐19 patients: A meta‐analysis study
    Bahareh Hajikhani, Tess Calcagno, Mohammad Javad Nasiri, Parnian Kord Jamshidi, Masoud Dadashi, Mehdi Goudarzi, Adrien A. Eshraghi, FACS, Mehdi Seyed Mirsaeidi · 2020 · Physiological Reports
  66. Covid‐19 and Liver Injury: Role of Inflammatory Endotheliopathy, Platelet Dysfunction, and Thrombosis
    M. McConnell, Reiichiro Kondo, N. Kawaguchi, Y. Iwakiri · 2021 · Hepatology Communications
  67. Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System
    Matthew A. Sparks, Andrew Michael South, Andrew D. Badley, Carissa Marrie Baker-Smith, DANIEL C. BATLLE, Biykem Bozkurt, Roberto Cattaneo, Steven D. Crowley, Louis J. Dell’Italia, Andria L. Ford et al. · 2020 · Hypertension
  68. Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysis
    Mohammad Shehab, Fatema Alrashed, Sameera Nadine Shuaibi, Dhuha Alajmi, Alan N. Barkun · 2021 · BMJ Open Gastroenterology
  69. COVID‐19, nausea, and vomiting
    Paul L. R. Andrews, Weigang Cai, John Anthony Rudd, Gareth John Sanger · 2020 · Journal of Gastroenterology and Hepatology
  70. The chronic kidney disease and acute kidney injury involvement in COVID-19 pandemic: A systematic review and meta-analysis
    Yafei Liu, Zhe Zhang, Xiao-Li Pan, Guo-Lan Xing, Ying Zhang, Zhang-Suo Liu, Sheng-Hao Tu · 2021 · PLoS ONE
  71. New Insights Into the Physiopathology of COVID-19: SARS-CoV-2-Associated Gastrointestinal Illness
    Christian Albert Devaux, Jean‐Christophe Lagier, Didier Raoult · 2021 · Frontiers in Medicine
  72. The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis
    Haizhou Wang, Peishan Qiu, Jing Liu, Fan Wang, Qiu Zhao · 2020 · Clinics and Research in Hepatology and Gastroenterology
  73. Evidence of SARS-CoV-2 Infection in Cells, Tissues, and Organs and the Risk of Transmission Through Transplantation
    Amaury Gaussen, Laura Hornby, Gary Rockl, Sheila F. O’Brien, Gilles Delage, Ruth Sapir‐Pichhadze, Steven J. Drews, Matthew John Weiss, Antoine Lewin · 2021 · Transplantation
  74. Virus strain from a mild COVID-19 patient in Hangzhou represents a new trend in SARS-CoV-2 evolution potentially related to Furin cleavage site
    Xi Jin, Kangli Xu, Penglei Jiang, Jiangshan Lian, Shaorui Hao, Hangping Yao, Hongyu Jia, Yimin Zhang, Lin Zheng, Nuoheng zheng et al. · 2020 · Emerging Microbes & Infections
  75. Classical and alternative receptors for SARS‐CoV‐2 therapeutic strategy
    Siti Fathiah Masre, Nurul Farhana Jufri, Farah Wahida Ibrahim, Sayyidi Hamzi Abdul Raub · 2020 · Reviews in Medical Virology
  76. The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime
    Marco Chilosi, Venerino E. Poletti, Claudia Ravaglia, Giulio Rossi, Alessandra Dubini, Sara Piciucchi, Federica Pedica, Vincenzo Bronte, Giovanni Pizzolo, Guido Martignoni et al. · 2021 · Modern Pathology
  77. Current Evidence for Minimally Invasive Surgery During the COVID-19 Pandemic and Risk Mitigation Strategies
    Sami Ahmed Chadi, Keegan Guidolin, Antonio Caycedo‐Marulanda, Abdu Sharkawy, Antonino Spinelli, Fayez A. Quereshy, Allan Okrainec · 2020 · Annals of Surgery
  78. Be aware of acute kidney injury in critically ill children with COVID-19
    Xiaowen Wang, Xingfeng Chen, Feng Tang, Wanjun Luo, Jian Fang, Chang Qi, Hua Ling Sun, Xiao Han, Xuehua Peng, Jianbo Shao · 2020 · Pediatric Nephrology
  79. Impact of COVID‐19 in Liver Disease Progression
    Miguel Ángel Martı́nez, Sandra Franco · 2021 · Hepatology Communications
  80. Probing infectious disease by single-cell RNA sequencing: Progresses and perspectives
    Geyang Luo, Qian Gao, Shuye Zhang, Bo Yan · 2020 · Computational and Structural Biotechnology Journal
  81. Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models
    Hsin-Liang Liu, I‐Jeng Yeh, Nam Nhut Phan, Yen‐Hung Wu, Meng‐Chi Yen, Jui‐Hsiang Hung, Chung-Chieh Chiao, Chien‐Fu Chen, Zhengda Sun, Jiazhen Jiang et al. · 2020 · Infection Genetics and Evolution
  82. Insights into SARS-CoV-2 Persistence and Its Relevance
    Belete Ayele Desimmie, Yonas Raru, Hesham Awadh, Peimei He, Samson Teka, Kara S. Willenburg · 2021 · Viruses
  83. The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2
    Amar Sarkar, Siobhán Harty, Andrew H. Moeller, Sabra L. Klein, Susan E. Erdman, Karl John Friston, Rachel N. Carmody · 2021 · Trends in Molecular Medicine
  84. Potential Effects of Coronaviruses on the Liver: An Update
    Xinyi Wang, Jianyong Lei, Zhihui Li, Lünan Yan · 2021 · Frontiers in Medicine
  85. Clinical Management of Diabetes Mellitus in the Era of COVID-19: Practical Issues, Peculiarities and Concerns
    Chrysi C. Koliaki, Anastasios Tentolouris, Ioanna Eleftheriadou, Andreas J. Melidonis, George Dimitriadis, Nikolaοs Tentolouris · 2020 · Journal of Clinical Medicine
  86. The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review
    Rui Rodrigues, Sofia Costa‐de‐Oliveira · 2021 · Microorganisms
  87. COVID-19 and the liver-related deaths to come
    Jean–Michel Pawlotsky · 2020 · Nature Reviews Gastroenterology & Hepatology
  88. Targeting Macrophages as a Therapeutic Option in Coronavirus Disease 2019
    Maria Gracia-Hernandez, Eduardo M. Sotomayor, Alejandro Villagra · 2020 · Frontiers in Pharmacology
  89. Advancing lung organoids for COVID-19 research
    Jelte van der Vaart, Mart Matthias Lamers, Bart L. Haagmans, Hans C. Clevers · 2021 · Disease Models & Mechanisms
  90. Vitamin D3 as Potential Treatment Adjuncts for COVID-19
    Lucia Malaguarnera · 2020 · Nutrients
  91. Cannabinoids in Medicine: Cancer, Immunity, and Microbial Diseases
    P. Śledziński, A. Nowak-Terpiłowska, J. Zeyland · 2020 · International Journal of Molecular Sciences
  92. ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues
    Sally Badawi, Bassam R. Ali · 2021 · Human Genomics
  93. Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
    Cecilia Theresa Costiniuk, Mohammad-Ali Jenabian · 2020 · Cytokine & Growth Factor Reviews
  94. Engineering a Model to Study Viral Infections: Bioprinting, Microfluidics, and Organoids to Defeat Coronavirus Disease 2019 (COVID-19)
    Anastasia I. Shpichka, Polina Bikmulina, Maria Peshkova, Nastasia V. Kosheleva, Зурина Ирина Михайловна, Ensieh Zahmatkesh, Niloofar Khoshdel Rad, Marina Lipina, Е. Н. Голубева, Denis V. Butnaru et al. · 2020 · International Journal of Bioprinting
  95. SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections
    Farhan Sachal Cyprian, Muhammad Umar Sohail, Ibrahim Abdelhafez, Salma Salman, Zakria Attique, Layla Kamareddine, Maha Al‐Asmakh · 2021 · International Journal of Infectious Diseases
  96. Gastrointestinal Bleeding in COVID‐19 Patients: A Systematic Review with Meta‐Analysis
    Giovanni Marasco, Marcello Fabio Maida, Gaetano Cristian Morreale, Massimo Licata, Matteo Renzulli, Cesare Cremon, Vincenzo Stanghellini, Giovanni Barbara · 2021 · Canadian Journal of Gastroenterology and Hepatology
  97. Epidemiological and clinical characteristics of 70 cases of coronavirus disease and concomitant hepatitis B virus infection: A multicentre descriptive study
    Jian Wu, Jiong Yu, Xiaowei Shi, Wei Li, Shu Song, Liangping Zhao, Xinguo Zhao, Jun Liu, Dawei Wang, Chengyuan Liu et al. · 2020 · Journal of Viral Hepatitis
  98. Human Organoids and Organs‐on‐Chips for Addressing COVID‐19 Challenges
    Yaqing Wang, Peng Wang, Jianhua Qin · 2022 · Advanced Science
  99. COVID-19: is there a link between the course of infection and pharmacological agents in diabetes?
    Tiziana Filardi, Susanna Morano · 2020 · Journal of Endocrinological Investigation
  100. Obesity alters Ace2 and Tmprss2 expression in lung, trachea, and esophagus in a sex-dependent manner: Implications for COVID-19
    Dylan C. Sarver, Guang William Wong · 2020 · Biochemical and Biophysical Research Communications